The Delhi High Court on Monday stayed a government notification restraining the sale of Pfizer’s cough syrup Corex. It also directed the government not to take coercive steps against the company. Further, the court directed the government to submit status reports of expert committee's findings based on which the sale of 344 drugs’ combination was banned across India.
